Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3585775

AZETIDINE COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    20.2.2018
  • EP published:
    6.4.2022
  • EP application number:
    18707874.6
  • Max expiry date:
    19.2.2038
  • Title in English:
    AZETIDINE COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
  • Language of the patent:
    English

Timeline

Today
20.2.2018EP application
6.4.2022EP Publication

Owner

  • Name:
    Sanofi
  • Address:
    54, rue La Boétie, 75008 Paris, FR

Inventor

  • Name:
    SCHWINK, Lothar
  • Address:
    65926 Frankfurt am Main, DE
  • Name:
    BUNING, Christian
  • Address:
    65926 Frankfurt am Main, DE
  • Name:
    GLOMBIK, Heiner
  • Address:
    65926 Frankfurt am Main, DE
  • Name:
    PÖVERLEIN, Christoph
  • Address:
    65926 Frankfurt am Main, DE
  • Name:
    RITTER, Kurt
  • Address:
    65926 Frankfurt am Main, DE
  • Name:
    HALLAND, Nis
  • Address:
    65926 Frankfurt am Main, DE
  • Name:
    LOHMANN, Matthias
  • Address:
    65926 Frankfurt am Main, DE

Priority

  • Number:
    17305189
  • Date:
    21.2.2017
  • Country:
    EP

Classification

  • Categories:
    C07D 401/14, C07D 403/14, A61K 31/506, A61P 5/48

Upload documents